SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-16-018920
Filing Date
2016-11-23
Accepted
2016-11-23 15:16:16
Documents
7

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM F-1 ff12016a1_therapixbio.htm F-1/A 3531418
2 ARTICLES OF ASSOCIATION OF THERAPIX BIOSCIENCES LTD. ff12016a1ex3i_therapix.htm EX-3.1 628731
3 CONSENT ff12016a1ex23i_therapixbio.htm EX-23.1 2472
4 GRAPHIC logorod_001.jpg GRAPHIC 3731
5 GRAPHIC image_001i.jpg GRAPHIC 6476
6 GRAPHIC image_002.jpg GRAPHIC 3163
7 GRAPHIC image_004.jpg GRAPHIC 21294
  Complete submission text file 0001213900-16-018920.txt   4211949
Mailing Address SCIENCE PARK, 18 EINSTIEN ST. P.O BOX 4122 NESS-ZIONA L3 7414002
Business Address SCIENCE PARK, 18 EINSTIEN ST. P.O BOX 4122 NESS-ZIONA L3 7414002 972-8-9396577
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: F-1/A | Act: 33 | File No.: 333-214458 | Film No.: 162016383
SIC: 2834 Pharmaceutical Preparations